Aplenzin Trademark Details

Aplenzin was registered on Tuesday, July 7, 2009 and is currently owned by Valeant Pharmaceuticals Luxembourg S.A.R.L. under the registration number 3650117 . This mark is alive with a status of Section 8 & 15-Accepted and Acknowledged. The last case file activity for this mark occured 9 years ago on Wednesday, August 6, 2014, according to the United State Patent & Trademark Office
Word Mark Aplenzin
Status Alive Registered 702 — Section 8 & 15-Accepted and Acknowledged

Current Owner

Valeant Pharmaceuticals Luxembourg S.A.R.L.

View all trademarks for Valeant Pharmaceuticals Luxembourg S.A.R.L.

Previous Owners

Sanofi-Aventis U.S. LLC of Bridgewater, NJ

View all trademarks for Sanofi-Aventis U.S. LLC
Other Trademarks for Sanofi-Aventis U.S. LLC

Biovail Laboratories International Srl

View all trademarks for Biovail Laboratories International Srl
Serial Number 77594316
Registration Number 3650117
Status Date Wednesday, August 6, 2014
Filing Date Wednesday, August 6, 2014
Registration Date Tuesday, July 7, 2009
Attorney Susan Upton Douglass

Correspondent

Susan Upton Douglass
Fross Zelnick Lehrman & Zissu, P.C.
866 United Nations Plaza
New York NY 10017

Case File Statements

Goods & Services Pharmaceutical Preparations and Substances for the Treatment of Diseases, Illnesses, Disorders, Ailments or Conditions of the Central Nervous System; Pharmaceutical Preparations and Substances for the Treatment of Depression, Depressive Disorders and Mental Illnesses; Antidepressants

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, October 20, 2008
First Use Anywhere Wednesday, March 11, 2009
First Use In Commerce Wednesday, March 11, 2009
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.